Literature DB >> 10455330

Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.

T Sakurada1, S Katsuyama, S Sakurada, M Inoue, K Tan-No, K Kisara, C Sakurada, H Ueda, J Sasaki.   

Abstract

1. Intrathecal (i.t.) injection of nociceptin at small doses (fmol order) elicited a behavioural response consisting of scratching, biting and licking in conscious mice. Here we have examined the involvement of substance P-containing neurons by using i.t. injection of tachykinin neurokinin (NK)1 receptor antagonists and substance P (SP) antiserum. 2. Nociceptin-induced behavioural response was evoked significantly 5 - 10 min after i.t. injection and reached a maximum at 10 - 15 min. Dose-dependency of the induced response showed a bell-shaped pattern from 0.375 - 30.0 fmol, and the maximum effect was observed at 3.0 fmol. 3. The behavioural response elicited by nociceptin (3.0 fmol) was dose-dependently inhibited by intraperitoneal (i.p.) administration of morphine. 4. The NK1 receptor antagonists, CP-96,345, CP-99,994 and sendide, inhibited nociceptin-induced behavioural response in a dose-dependent manner. A significant antagonistic effect of [D-Phe7, D-His9]SP (6 - 11), a selective antagonist for SP receptors, was observed against nociceptin-induced response. The NK2 receptor antagonist, MEN-10376, had no effect on the response elicited by nociceptin. 5. Pretreatment with SP antiserum resulted in a significant reduction of the response to nociceptin. No significant reduction of nociceptin-induced response was detected in mice pretreated with NKA antiserum. 6. The N-methyl-D-aspartate (NMDA) receptor antagonists, dizocilpine (MK-801) and D(-)-2-amino-5-phosphonovaleric acid (APV) (D-APV), and L-NG-nitro arginine methyl ester (L-NAME), a nitric oxide (NO) synthase inhibitor, failed to inhibit nociceptin-induced behavioural response. 7. off present results suggest that SP-containing neurons in the mouse spinal cord may be involved in elicitation of scratching, biting and licking behaviour following i.t. injection of nociceptin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455330      PMCID: PMC1566145          DOI: 10.1038/sj.bjp.0702698

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

Review 1.  Nitric oxide, a novel neuronal messenger.

Authors:  D S Bredt; S H Snyder
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

2.  Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines.

Authors:  M J Wick; S R Minnerath; S Roy; S Ramakrishnan; H H Loh
Journal:  Brain Res Mol Brain Res       Date:  1995-09

3.  Characterization of nociceptin hyperalgesia and allodynia in conscious mice.

Authors:  N Hara; T Minami; E Okuda-Ashitaka; T Sugimoto; M Sakai; M Onaka; H Mori; T Imanishi; K Shingu; S Ito
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

4.  In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.

Authors:  G E DeLander; J J Wahl
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

5.  Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type.

Authors:  J R Bunzow; C Saez; M Mortrud; C Bouvier; J T Williams; M Low; D K Grandy
Journal:  FEBS Lett       Date:  1994-06-27       Impact factor: 4.124

6.  Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15.

Authors:  J L Montiel; F Cornille; B P Roques; F Noble
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

7.  The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.

Authors:  T Sakurada; Y Manome; K Tan-No; S Sakurada; K Kisara
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

8.  Pharmacological characterization of orphanin FQ/nociceptin and its fragments.

Authors:  G C Rossi; L Leventhal; E Bolan; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

9.  Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family.

Authors:  Y Chen; Y Fan; J Liu; A Mestek; M Tian; C A Kozak; L Yu
Journal:  FEBS Lett       Date:  1994-06-27       Impact factor: 4.124

10.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  14 in total

Review 1.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 2.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  Central N/OFQ-NOP Receptor System in Pain Modulation.

Authors:  Norikazu Kiguchi; Huiping Ding; Mei-Chuan Ko
Journal:  Adv Pharmacol       Date:  2015-12-17

Review 4.  Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics.

Authors:  Norikazu Kiguchi; Huiping Ding; Shiroh Kishioka; Mei-Chuan Ko
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

5.  Nociceptin (1 - 7) antagonizes nociceptin-induced hyperalgesia in mice.

Authors:  T Sakurada; S Sakurada; S Katsuyama; C Sakurada; K Tan-No; L Terenius
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Authors:  Hongkui Zeng; Alexander Gragerov; John G Hohmann; Maria N Pavlova; Brian A Schimpf; Hui Xu; Long-Jun Wu; Hiroki Toyoda; Ming-Gao Zhao; Alex D Rohde; Galina Gragerova; Rene Onrust; John E Bergmann; Min Zhuo; George A Gaitanaris
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

7.  Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

Authors:  Mei-Chuan Ko; Norah N Naughton
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

Review 8.  The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.

Authors:  Ann P Lin; Mei-Chuan Ko
Journal:  ACS Chem Neurosci       Date:  2012-11-06       Impact factor: 4.418

9.  Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.

Authors:  Mei-Chuan Ko; James H Woods; William E Fantegrossi; Chad M Galuska; Jürgen Wichmann; Eric P Prinssen
Journal:  Neuropsychopharmacology       Date:  2009-03-11       Impact factor: 7.853

10.  Acid-induced mesenteric hyperemia in rats: role of CGRP, substance P, prostaglandin, adenosine, and histamine.

Authors:  Felix W Leung; Fumihiro Iwata; Kyoji Seno; Joseph W C Leung
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.